177 related articles for article (PubMed ID: 37339766)
21. In Southern Nigeria
Emukah E; Rakers LJ; Kahansim B; Miri ES; Nwoke BEB; Griswold E; Saka Y; Anagbogu I; Davies E; Ityonzughul C; D'Ambrosio M; Bakalar M; Fletcher DA; Nutman T; Kamgno J; Richards FO
Am J Trop Med Hyg; 2018 Jul; 99(1):116-123. PubMed ID: 29761763
[TBL] [Abstract][Full Text] [Related]
22. [Retinal hemorrhages after ivermectin treatment for onchocerciasis in a patient with Loa loa microfilaremia].
Moussala M; Fobi G; Ongolo Zogo P; Bella Hiag LA; Bengono G; McMoli TE
J Fr Ophtalmol; 2004 Jan; 27(1):63-6. PubMed ID: 14968080
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.
Wanji S; Tendongfor N; Esum M; Ndindeng S; Enyong P
Med Microbiol Immunol; 2003 Feb; 192(1):15-21. PubMed ID: 12592559
[TBL] [Abstract][Full Text] [Related]
24. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
Wanji S; Tendongfor N; Esum M; Yundze SS; Taylor MJ; Enyong P
Filaria J; 2005 Apr; 4(1):2. PubMed ID: 15817124
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery.
Ayiseh RB; Mbah GE; Monya E; Ndi EM; Sakanari J; Lustigman S; Cho-Ngwa F
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011135. PubMed ID: 36827447
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of capillary and venous blood samples in the detection of Loa loa and Mansonella perstans microfilaraemia using light microscopy.
Mischlinger J; Manego RZ; Mombo-Ngoma G; Ekoka Mbassi D; Hackbarth N; Ekoka Mbassi FA; Davi SD; Kreuzmair R; Veletzky L; Hergeth J; Ndoumba WN; Pitzinger P; Groger M; Matsiegui PB; Adegnika AA; Agnandji ST; Lell B; Ramharter M
PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009623. PubMed ID: 34398886
[TBL] [Abstract][Full Text] [Related]
27. Assessing Hypoendemic Onchocerciasis in
Rakers LJ; Emukah E; Kahansim B; Nwoke BEB; Miri ES; Griswold E; Davies E; Ityonzughul C; Anyaike C; Agbi P; Richards FO
Am J Trop Med Hyg; 2020 Dec; 103(6):2328-2335. PubMed ID: 32959756
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
Blok DJ; Kamgno J; Pion SD; Nana-Djeunga HC; Niamsi-Emalio Y; Chesnais CB; Mackenzie CD; Klion AD; Fletcher DA; Nutman TB; de Vlas SJ; Boussinesq M; Stolk WA
Clin Infect Dis; 2021 Jun; 72(12):e1047-e1055. PubMed ID: 33289025
[TBL] [Abstract][Full Text] [Related]
29. Rapid assessment method for prevalence and intensity of Loa loa infection.
Takougang I; Meremikwu M; Wandji S; Yenshu EV; Aripko B; Lamlenn SB; Eka BL; Enyong P; Meli J; Kale O; Remme JH
Bull World Health Organ; 2002; 80(11):852-8. PubMed ID: 12481206
[TBL] [Abstract][Full Text] [Related]
30. Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
Johnson O; Giorgi E; Fronterrè C; Amoah B; Atsame J; Ella SN; Biamonte M; Ogoussan K; Hundley L; Gass K; Diggle PJ
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010189. PubMed ID: 35139080
[TBL] [Abstract][Full Text] [Related]
31. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
[TBL] [Abstract][Full Text] [Related]
32. Implementation of test-and-treat with doxycycline and temephos ground larviciding as alternative strategies for accelerating onchocerciasis elimination in an area of loiasis co-endemicity: the COUNTDOWN consortium multi-disciplinary study protocol.
Wanji S; Nji TM; Hamill L; Dean L; Ozano K; Njouendou AJ; Abong RA; Obie ED; Amuam A; Ekanya R; Ndongmo WPC; Ndzeshang BL; Fung EG; Nnamdi DB; Nkimbeng DA; Teghen S; Kah E; Piotrowski H; Forrer A; Khan JAM; Woode ME; Niessen L; Watson V; Njoumemi Z; Murdoch ME; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
Parasit Vectors; 2019 Dec; 12(1):574. PubMed ID: 31801631
[TBL] [Abstract][Full Text] [Related]
33. Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis.
Boullé C; Chesnais CB; Kamgno J; Gardon J; Chippaux JP; Ranque S; Garcia A; Pion SD; Boussinesq M
Lancet Microbe; 2023 Feb; 4(2):e93-e101. PubMed ID: 36646105
[TBL] [Abstract][Full Text] [Related]
34. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
35. Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin.
Duong TH; Kombila M; Ferrer A; Bureau P; Gaxotte P; Richard-Lenoble D
Trans R Soc Trop Med Hyg; 1997; 91(5):592-3. PubMed ID: 9463677
[TBL] [Abstract][Full Text] [Related]
36. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
[TBL] [Abstract][Full Text] [Related]
37. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
[TBL] [Abstract][Full Text] [Related]
38. [The efficacy and tolerance of ivermectin (Mectizan) prescribed for the patient with multiple filarial infections (Loa loa/Onchocerca and/or M. perstans)].
Richard-Lenoble D; Kombila M; Chandenier J; Gaxotte P
Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):65-71. PubMed ID: 2743519
[TBL] [Abstract][Full Text] [Related]
39. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
Twum-Danso NA; Meredith SE
Trop Med Int Health; 2003 Sep; 8(9):820-31. PubMed ID: 12950668
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of
Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J
Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
